Role of Parkin in Familial and Idiopathic Parkinson's Disease
Role of Parkin in Familial and Idiopathic Parkinson's Disease
批准号:
9481344
负责人:
Matthew J Lavoie
金额:
$38.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2021-05-31
关键词:
AffectApoptosisBH3 DomainBNIP3L geneBax proteinBiologyCell DeathComprehensionCytoplasmCytosolDNA Sequence AlterationDataDiseaseEngineeringEtiologyFundingGoalsHumanIdiopathic Parkinson DiseaseInhibition of ApoptosisLightLinkMaintenanceMass Spectrum AnalysisMitochondriaModelingModificationMolecularMotorNatureNerve DegenerationNeurodegenerative DisordersNeuronsPINK1 geneParkinson DiseasePathogenesisPathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesPlayPluripotent Stem CellsPost-Translational Protein ProcessingProcessProtein FamilyProteinsRegulationReportingRoleStressSubstrate DomainTertiary Protein StructureTestingTherapeuticTherapeutic InterventionUbiquitinationWorkbasebiological adaptation to stresscytochrome cdopaminergic neuronexperimental studyhuman stem cellsinnovationinsightloss of function mutationnervous system disorderneuroprotectionnew therapeutic targetnovelparkin gene/proteinpro-apoptotic proteinprotective effectrecruitstem cell differentiationstressortargeted treatmentubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-
motor disturbances. While the etiology of the disease is unknown, genetic mutations responsible
for familial forms of PD likely provide critical molecular insights into the underlying mechanisms of idiopathic
disease. Loss-of-function mutations in the ubiquitin E3 ligase parkin are the most common cause of autosomal
recessive PD. Parkin is now widely recognized as a pro-survival protein that possesses broad ranging effects
on mitochondrial biology, and beyond. A more complete comprehension of these functions will will lead to a
firmer understanding of the neurodegenerative process in PD, as well as the identification of new pathways
that may be targeted for disease modification. The long-term goal of our work is to uncover the molecular
machinery responsible for parkin's protective effects in neurons. We propose that both the cytosolic and
mitochondrial-localized pools of parkin play important roles in the maintenance of healthy neurons. This
application will explore the role of cytosolic parkin in its neuro-protective function in human neurons. Using
engineered isogenic and patient based WT and parkin null pluripotent stem cells differentiated to human
neuronal fates, we will uncover the conditions that activate the cytoplasmic pool of parkin. We will identify the
upstream proteins that control parkin activation and its protection against cell death in human neurons. Then,
we will explore the role of BH3 domains in the recognition of an expanding class of putative substrates of
cytoplasmic parkin E3 ligase activity. The pathways found to regulate neuronal parkin function may shed light
on innovative targets for therapeutic intervention to up-regulate parkin activity and induce neuro-protection in
neurologic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease
-
批准号:9791022
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
-
批准号:10241552
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
-
批准号:10459599
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
The Activation of LRRK2 by Alpha-Synuclein
-
批准号:8925936
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Matthew J Lavoie
-
依托单位:
The Activation of LRRK2 by Alpha-Synuclein
-
批准号:8823867
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2014
-
负责人:Matthew J Lavoie
-
依托单位:
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)
-
批准号:8191191
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2011
-
负责人:Matthew J Lavoie
-
依托单位:
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)
-
批准号:8259427
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2011
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8451475
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:7984298
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8101127
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8259799
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease
-
批准号:8055551
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:10197226
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:10170978
-
项目类别:
-
资助金额:$4.28万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8658153
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8516663
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease
-
批准号:7870069
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation and Modification in Neurodegeneration
-
批准号:7913494
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation and Modification in Neurodegeneration
-
批准号:7371015
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2006
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation and Modification in Neurodegeneration
-
批准号:7201629
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2006
-
负责人:Matthew J Lavoie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: